The effect of chinese medicine pu-ren-dan on pancreatic angiogenesis in high fat diet/streptozotocin-induced diabetic rats

Indian Journal of Pharmacology

Volumn 45, Issue 6, 2013, Pages 556-562

  Lu, Binan ^a   Bai, Yongfei ^a   Du, Ziliang ^a   Chen, Shu ^a   Deligema, D ^a   Pang, Zongran ^a  

^a MINZU UNIVERSITY OF CHINA   (China)

Author keywords

Pancreatic angiogenic factors; Traditional Chinese medicine Pu Ren Dan; Type 2 diabetes mellitus

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANGIOSTATIN; ANTIDIABETIC AGENT; ENDOSTATIN; GLUCOSE; HERBACEOUS AGENT; INSULIN; JIANG TANG TONG MAI; LIPID; METFORMIN; PU REN DAN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

PANCREATIC ANGIOGENIC FACTORS; TRADITIONAL CHINESE MEDICINE PU-REN-DAN; TYPE-2 DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; INSULIN; MALE; NEOVASCULARIZATION, PATHOLOGIC; PANCREAS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, TIE-2; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84890064447     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.121364     Document Type: Article

References (26)

1. Keymel S, Heinen Y, Balzer J, Rassaf T, Kelm M, Lauer T,et al. Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus. Am J Cardiovasc Dis 2011; 1: 68-75.
2. Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007; 31: 705-14.
3. Maeshima Y, Makino H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 2010; 3: 13.
4. Willard AL, Herman IM. Vascular complications and diabetes: Current therapies and future challenges. J Ophthalmol 2012; 2012: 209538.
5. Olsson R, Carlsson PO. The pancreatic islet endothelial cell: Emerging roles in islet function and disease. Int J Biochem Cell Biol 2006; 38: 710-4.
6. Pang ZR, Jia CH, Liu BS, Liu XG, Cui J. Therapy effect on Type 2 diabetes of PRD capsule in 38 patients. Shandong JTradit Chin Med 2003; 3: 137-9.
7. Pang ZR, Jia CH, Liu BS, Yang HM, Liu XG, Cui J. Regulation effect of PRD capsule on blood glucose and lipid metabolism. Study JTradit Chin Med 2003; 6: 896-7.
8. Pang ZR, Liu ZH, Su XH, Wang ZH, Zhang BL. Effects of PuRen Dan submicron powder on ET-1,NO,FFAs in large blood vessel injury rats with obesity T2DM. Chin J Gerontol 2011; 10: 1779-80.
9. Liu DS, Gao W, Lin WW, Hao YY, Zhong LH, Li W,et al. Effects of the Chinese Yi-Qi-Bu-Shen Recipe extract on brainstem auditory evoked potential in rats with diabetes. J Ethnopharmacol 2011; 137: 414-20.
10. Rizza RA. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: Implications for therapy. Diabetes 2010; 59: 2697-707.
11. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab 2000; 11: 375-8.
12. Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007; 31: 705-14.
13. Nakagawa T, Kosugi T, Haneda M, Rivard CJ, Long DA. Abnormal angiogenesis in diabetic nephropathy. Diabetes 2009; 58: 1471-8.
14. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S,et al. Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 2003; 278: 2997-3005.
15. Bayer A, Sahin A. Changes of extracellular matrix of the cornea in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2010; 248: 291, 293.
16. Ryu JM, Lee MY, Yun SP, Han HJ. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways. J Cell Physiol 2010; 224: 59-70.
17. Zhu M, Bi X, Jia Q, Shangguan S. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor. Biomed Pharmacother 2010; 64: 208-13.
18. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999; 274: 11721-6.
19. Ooi CP, Yassin Z, Hamid TA. Momordicacharantia for type 2 diabetes mellitus. Cochrane Database Syst Rev 2012; 8: D7845.
20. Patel D, Prasad S, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012; 4: 320-30.
21. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity-a review of ten years of herbal medicine research (1990-2000). Int J Diabetes Metab 2006; 14: 1-25.
22. Yang N, Chen P, Tao Z, Zhou N, Gong X, Xu Z, et al. Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice. Acta Biochim Biophys Sin (Shanghai) 2012; 12: 999-1005.
23. Li C, Cai F, Yang Y, Zhao X, Wang C, Li J,et al. Tetrahydroxystilbeneglucoside ameliorates diabetic nephropathy in rats: Involvement of SIRT1 and TGF-beta1 pathway. Eur J Pharmacol 2010; 649: 382-9.
24. Hu J, Li YL, Li ZL, Li H, Zhou XX, Qiu PC,et al. Chronic Supplementation of Paeonol Combined with Danshensu for the Improvement of Vascular Reactivity in the Cerebral Basilar Artery of Diabetic Rats. Int J Mol Sci 2012; 11: 14565-78.
25. Zhu LH, Wang L, Wang D, Jiang H, Tang QZ, Yan L,et al. Puerarin attenuates highglucose- and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med 2010; 48: 471-82.
26. Shi W, Wu JY, Xiang CC, Tang AH, Huang LW. Effect of Hirudomedicinalis injection on diabetic nephropathy in 57 patients. Shaanxi J Tradit Chin Med 2007; 4: 401-3.